This webinar will take a look at potential changes facing FDA-regulated life sciences industry in 2021. Presented by James Boiani of Epstein Becker and Green.
James A. Boiani | Member | Epstein Becker & Green, P.C.
James A. Boiani is a Member of Epstein Becker & Green in the Health Care and Life Sciences practice, in the firm's Washington, DC, office. He has extensive experience in FDA and CLIA legal and regulatory matters, having worked with large and small medical device companies (including many in vitro diagnostic companies), pharmaceutical companies, clinical laboratories, and trade associations in the life sciences industry on a variety of FDA- and CLIA-related issues.
Mr. Boiani's practice focuses on the following: